Spironolactone hepatitis in primary hyperaldosteronism.
D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D008099:Liver / Q000201:enzymology; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use
D013148:Spironolactone